MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1641 to 1660 of 166,322 approvalsPage 83 of 8317

Metformin Hydrochloride Tablets

Approval Number: 国药准字H20253297
Registration: Jan 24, 2025

Macrogol Sodium Potassium Powder

Approval Number: 国药准字H20253275
Registration: Jan 24, 2025

Menatetrenone Soft Capsules

Approval Number: 国药准字H20253282
Registration: Jan 24, 2025

Simethicone Emulsion

Approval Number: 国药准字H20253295
Registration: Jan 24, 2025

Efsubaglutide Alfa Injection

Approval Number: 国药准字S20250009
Registration: Jan 24, 2025

Tulobuterol Patch

Approval Number: 国药准字H20253279
Registration: Jan 24, 2025

Nicorandil for Injection

Approval Number: 国药准字H20253306
Registration: Jan 24, 2025

Empagliflozin Tablets

Approval Number: 国药准字H20253229
Registration: Jan 24, 2025

Roxadustat Capsules

Approval Number: 国药准字H20253322
Registration: Jan 24, 2025

Regorafenib Tablets

Approval Number: 国药准字HJ20250012
Registration: Jan 24, 2025
m/s aizant drug research solutions private limited

Bumetanide Injection

Approval Number: 国药准字H20253233
Registration: Jan 24, 2025

Potassium Chloride Oral Solution

Approval Number: 国药准字H20253290
Registration: Jan 24, 2025

Loxoprofen Sodium Cataplasms

Approval Number: 国药准字H20253228
Registration: Jan 24, 2025

Compound Sodium Acetate Ringer’s Injection

Approval Number: 国药准字H20253318
Registration: Jan 24, 2025

盐酸头孢甲肟

Approval Number: 国药准字H20060379
Registration: Jan 22, 2025

Estradiol Valerate Tablets

Approval Number: 国药准字HJ20160679
Registration: Jan 22, 2025

Piracetam Tablets

Approval Number: 国药准字H20247334
Registration: Jan 22, 2025

萝芙木

Approval Number: 国药准字H45021209
Registration: Jan 22, 2025

Estradiol Valerate Tablets

Approval Number: 国药准字HJ20160678
Registration: Jan 22, 2025

Ribavirin and Glucose Injection

Approval Number: 国药准字H20045506
Registration: Jan 21, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.